During the past decade, AURA Paris Plaisance conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AURA Paris Plaisance" #1 sponsor was "Groupe Hospitalier Paris Saint Joseph" with 4 trials, followed by "Jean-Philippe Bertocchio" with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Theradial" with 1 trials sponsored and "University Hospital, Brest" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AURA Paris Plaisance" #1 collaborator was "Central Hospital, Nancy, France" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "AURA Paris Plaisance" are "Blood Pressure" (1 trials), "Body Weight" (1 trials), "COVID" (1 trials), "Chronic Kidney Diseases" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "AURA Paris Plaisance" in a lesser frequency.

Most popular intervention types in "AURA Paris Plaisance" are "Drug" (4 trials), "Biological" (1 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alkali" (1 trials), "BHR Case" (1 trials), "Control" (1 trials), "Cutaneous conductance to chlorine by SUDOSCAN" (1 trials) and "Liraglutide" (1 trials). Other intervention names were less common.

The vast majority of trials in "AURA Paris Plaisance" are 9 trials for "All" genders.

Currently, there are NaN active trials in "AURA Paris Plaisance". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in AURA Paris Plaisance, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AURA Paris Plaisance, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".